Literature DB >> 15225809

Biological actions and mechanism of action of calbindin in the process of apoptosis.

Sylvia Christakos1, Yan Liu.   

Abstract

Although it was originally proposed that the major role of calbindin is to facilitate the vitamin D dependent movement of calcium through the cytosolic compartment of the intestinal or renal cell, we found that calbindin also has a major role in different cell types in protecting against apoptotic cell death. Calbindin, which buffers calcium, can inhibit apoptosis induced by different proapoptotic stimuli. Expression of calbindin-D(28k) in neural cell suppressed the proapoptotic actions of presenilin-1, which is causally linked to familial Alzheimer's disease, by preventing calcium mediated mitochondrial damage and the subsequent release of cytochrome c. Calbindin, by buffering intracellular calcium can also protect HEK 293 kidney cells from parathyroid hormone induced apoptosis that was found to be mediated by a phospholipase C dependent increase in intracellular calcium. In addition, cytokine mediated destruction of pancreatic beta cells can be prevented by calbindin. Induction by cytokines of nitric oxide, peroxynitrite and lipid hydroperoxide production was significantly decreased in calbindin expressing beta cells. Thus, calbindin-D(28k), by inhibiting free radical formation, can protect islet beta cells from autoimmune destruction in type 1 diabetes. Calbindin-D(28k) can also protect against apoptosis in bone cells. Calbindin was found to block apoptosis in osteocytic and osteoblastic cells. Our findings suggest that calbindin is capable of directly inhibiting the activity of caspase-3, a common downstream effector of multiple apoptotic signaling pathways, and that this inhibition results in an inhibition of tumor necrosis factor (TNFalpha) and glucocorticoid induced apoptosis in bone cells. Thus, while part of calbindin's protective effect may result from buffering rises in intracellular calcium, other mechanisms of action, such as inhibition of caspase activity, also play a significant role in the prevention of apoptosis by calbindin-D(28k). These findings have implications for the prevention of degeneration in different cell types and therefore could prove important for the therapeutic intervention of many diseases, including diabetes and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225809     DOI: 10.1016/j.jsbmb.2004.03.007

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  17 in total

1.  The absence of the calcium-buffering protein calbindin is associated with faster age-related decline in hippocampal metabolism.

Authors:  Herman Moreno; Nesha S Burghardt; Daniel Vela-Duarte; James Masciotti; Fan Hua; André A Fenton; Beat Schwaller; Scott A Small
Journal:  Hippocampus       Date:  2011-05-31       Impact factor: 3.899

2.  New insights into the function and regulation of vitamin D target proteins.

Authors:  Sylvia Christakos; Puneet Dhawan; Xiaorong Peng; Alexander G Obukhov; Martha C Nowycky; Bryan S Benn; Yan Zhong; Yan Liu; Qi Shen
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12-22       Impact factor: 4.292

Review 3.  Vitamin D and diabetes mellitus: Causal or casual association?

Authors:  M Grammatiki; E Rapti; S Karras; R A Ajjan; Kalliopi Kotsa
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

Review 4.  Emerging roles of the single EF-hand Ca2+ sensor tescalcin in the regulation of gene expression, cell growth and differentiation.

Authors:  Ksenia G Kolobynina; Valeria V Solovyova; Konstantin Levay; Albert A Rizvanov; Vladlen Z Slepak
Journal:  J Cell Sci       Date:  2016-09-08       Impact factor: 5.285

5.  Downregulation of calbindin 1, a calcium-binding protein, reduces the proliferation of osteosarcoma cells.

Authors:  Zhengxiang Huang; Guojun Fan; Dongliang Wang
Journal:  Oncol Lett       Date:  2017-03-28       Impact factor: 2.967

6.  Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers.

Authors:  Emily B Southard; Alanna Roff; Tracey Fortugno; John P Richie; Matthew Kaag; Vernon M Chinchilli; Jarmo Virtamo; Demetrius Albanes; Stephanie Weinstein; Robin Taylor Wilson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-15       Impact factor: 4.254

7.  Comparative proteomic analysis of kidney development-related proteins in the pig.

Authors:  Young-Joo Jeon; Jumi Kim; Jung-Il Chae
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-04-13       Impact factor: 2.416

8.  Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.

Authors:  Rudolf Lichtenfels; Sven P Dressler; Monica Zobawa; Christian V Recktenwald; Angelika Ackermann; Derek Atkins; Michael Kersten; Andrea Hesse; Maria Puttkammer; Friedrich Lottspeich; Barbara Seliger
Journal:  Mol Cell Proteomics       Date:  2009-09-14       Impact factor: 5.911

9.  Structural characterization of the conformational change in calbindin-D28k upon calcium binding using differential surface modification analyzed by mass spectrometry.

Authors:  Carey A Hobbs; Leesa J Deterding; Lalith Perera; Benjamin G Bobay; Richele J Thompson; Thomas A Darden; John Cavanagh; Kenneth B Tomer
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

10.  Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter in response to serum deprivation.

Authors:  Asghar Hajibeigi; Elhadji M Dioum; Jianfei Guo; Orhan K Öz
Journal:  Biochem Biophys Res Commun       Date:  2015-08-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.